Topic Highlight
Copyright ©The Author(s) 2015.
World J Gastroenterol. Oct 21, 2015; 21(39): 11044-11052
Published online Oct 21, 2015. doi: 10.3748/wjg.v21.i39.11044
Table 1 Non-invasive serum tests for the assessment of liver fibrosis and corresponding stages of alcoholic liver disease diagnosed
TestVariablesALD stage assessed
AST:ALT ratioALT, AST≥ F1, F4
HAHAF4
PGAPT, GGT, apolipoprotein-A1F4
PGAAPT, GGT, apolipoprotein-A1, α2-macroglobulin
FibroTest®Haptoglobin, α2-macroglobulin, apolipoprotein-A1, bilirubin, GGT≥ F3, F4
FibrometerA®Age, weight, glucose, AST, ALT, PLT count, ferritin≥ F3, F4
FIB-4Age, AST, ALT, platelet count≥ F3
Hepascore®Age, sex, bilirubin, GGT, α2-macroglobulin, HA≥ F3, F4
APRIAST, platelet count≥ F2, F4
ELF test™HA, PIIINP, TIMP-1≥ F3, F4
Forns indexAge, platelet count, total cholesterol, GGT≥ F3, F4
Table 2 Non-invasive serum tests to diagnose fibrosis in patients with alcoholic liver disease and corresponding diagnostic indexes
TestCut-offsF3
F4
SensitivitySpecificityAUROCSensitivitySpecificityAUROC
PGA< 2NANA0.840%83%NA
> 9NANANA86%100%0.89
PGAA< 3NANA0.86NANANA
> 12NANANANANA0.83
Hyaluronic acid, μL> 5583.0%69%NANANANA
> 60NANANA100%60%-86%2NA
> 100NANANA89%87%NA
> 250NANANA100%69%0.78
APRI< 0.5NANANANANANA
> 1.513.2%77.6%0.43-0.72NANANA
< 1NANANANANANA
> 29.4%96.6%NA16.9%86.4%0.56-0.792
FIB-4< 1.45NANA0.7NANA0.8
> 3.25NANA0.7NANA0.8
FibroTest®< 0.3 (0.3-1.581)84.0%66%0.79100%50%0.84
> 0.7 (0.7-1.01)55.0%93%0.8391%87%0.94
FibroMeter®NA91.8%92.3%0.82-0.88291.8%92.3%0.85-0.942
ELF test™< 0.43193.3%100%0.9493.3%100%0.94
> 9.574.4%92.4%NA74.4%92.4%NA
Hepascore®NANANA0.76-0.832NANA0.76-0.922
FornsNANANA0.38NANA0.38